Findings from the GOG-3007 study suggest everolimus plus letrozole might be effective in advanced persistent or recurrent endometrial carcinoma.
Bryant Furlow
Advertisement
Articles by Bryant Furlow
Advertisement
Latest Updated Articles
- Everolimus Plus Letrozole Effective in Endometrial Carcinoma
Published: March 27th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
2
Forming CUTNETs: A Joint Venture Between Surgery and Oncology in NETs
3
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
4
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
5
